Saturday 17 October 2026
Export STE’s income statement to Excel — free account
STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
222.66
1.67
−0.74%
Follow STE
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
10.10% | 10.41% | 11.33% | 11.35% | |
Piotroski F-Score |
8 | 9 | 9 | 8 | |
| 6.67% | 6.87% | 7.49% | 7.62% | ||
ROIC |
7.07% | 7.24% | 7.92% | 8.27% | |
Return on Tangible Assets |
20.81% | 20.24% | 22.94% | 24.14% | |
Average Days of Receivables |
60.63 | 62.04 | 67.20 | 61.25 | |
Free Cash Flow per Share |
9.86 | 9.54 | 10.01 | 9.59 | |
Free Cash Flow |
970.40 | 936.70 | 982.90 | 936.00 | |
Capital Expenditures |
(331.00) | (330.10) | (358.50) | (352.50) | |
| Other line items | |||||
Cash ROIC |
10.50% | 9.87% | 10.27% | 9.75% | |
Accounts Receivable Turnover |
6.10 | 6.12 | 5.56 | 6.16 | |
Accounts Payable Turnover |
11.68 | 12.45 | 10.68 | 10.40 | |
Inventory Turnover |
4.72 | 4.92 | 5.46 | 4.96 | |
Average Days of Payables |
35.49 | 31.94 | 37.37 | 37.44 | |
Days of Inventory on Hand |
75.65 | 75.46 | 69.68 | 77.48 | |
Tax Rate |
(0.24) | (0.24) | (0.25) | (0.26) | |
Research and Development Expense of Revenue |
1.92% | 1.92% | 1.90% | 1.91% | |
Selling, General and Administrative Expense of Revenue |
24.08% | 23.84% | 23.72% | 23.58% | |
Share Based Compensation of Revenue |
1.02% | 1.01% | 1.04% | 1.04% | |
Interest Coverage |
14.53 | 15.94 | 18.15 | 18.84 | |
Operating CF/Net income |
1.89 | 1.79 | 1.71 | 1.60 | |
Depreciation/Fixed assets |
0.23 | 0.23 | 0.23 | 0.23 | |
Capex/Depreciation |
(0.68) | (0.68) | (0.74) | (0.72) | |
Revenue per Share |
57.95 | 59.35 | 60.45 | 61.86 | |
Operating CF per Share |
13.23 | 12.90 | 13.66 | 13.20 | |
Capex per Share |
(3.36) | (3.36) | (3.65) | (3.61) | |
Capex to Sales |
0.06 | 0.06 | 0.06 | 0.06 |
Columns are period end dates